`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`GOOGLE LLC,
`
`Petitioner,
`
`v.
`
`JAWBONE INNOVATIONS, LLC,
`
`Patent Owner.
`
`
`
`
`
`
`
`
`Case IPR2022-01124
`
`Patent No. 11,122,357
`
`
`
`
`
`
`
`
`PETITIONER’S PRE-INSTITUTION REPLY
`
`
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 11,122,357
`
`I.
`II.
`
`Table of Contents
`
`The Petition Presents Compelling Evidence of Unpatentability ..................... 1
`The Fintiv Factors Favor Institution ................................................................ 3
`A.
`Fintiv Factors 2, 3, 4, and 6 Favor Institution ....................................... 3
`B.
`Factors 1 and 5 Are Neutral .................................................................. 5
`III. Conclusion ....................................................................................................... 5
`
`
`i
`
`
`
`The Board should institute review and not apply the Fintiv factors. But even
`
`if applied, the most relevant Fintiv factors (2, 3, and 4) favor institution.
`
`I.
`
`The Petition Presents Compelling Evidence of Unpatentability
`The Board will not deny institution based on Fintiv “where a petition presents
`
`compelling evidence of unpatentability.” Memo. from Director Vidal, Interim
`
`Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel
`
`District Court Litigation at 2 (U.S.P.T.O. June 21, 2022) (“Int. Procedure”). Here,
`
`Petitioner has shown such compelling evidence. For example, Petitioner has
`
`demonstrated that the combination of Kanamori (Ex. 1005), McCowan (Ex. 1006),
`
`and Elko (Ex. 1009) renders all challenged claims obvious. Paper 1 (“Pet.”) 14-76.
`
`Patent Owner’s contrary arguments lack merit. Paper 6 (“Prelim. Resp.”) 6-
`
`13. Patent Owner argues that Dr. Vipperman did not explain how he performed his
`
`linear-response simulations. Prelim. Resp. 7. To the contrary, the section of Dr.
`
`Vipperman’s declaration titled “Simulations of Virtual Microphone Responses”
`
`explained in detail the equations used for each simulation and the values of the
`
`variables in each equation based on Kanamori, McCowan, and the knowledge of a
`
`POSITA. Ex. 1003, ¶¶ 50-60. Patent Owner failed to identify any details missing
`
`from this explanation that would have prevented a POSITA from recreating his
`
`simulations. Patent Owner also argued that “1000 Hz is not a valid speech signal.”
`
`Prelim. Resp. 7-11. This argument ignores that the ’357 patent repeatedly refers to
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 11,122,357
`“a 1 kHz speech source.” Ex. 1001, 2:54-57, 2:62-64, 11:40-42, 12:39-41.
`
`Additionally, contrary to Patent Owner’s argument, the Petition provided ample
`
`evidence of a motivation to combine Kanamori and McCowan to make Kanamori’s
`
`noise-cancellation effective for near-field devices like headsets. Pet. 21-40. Such a
`
`modification does not “destroy the objective of the prior art,” Prelim. Resp. 13, but
`
`rather modifies it for a well-known device (e.g., headsets), supported by Kanamori,
`
`state-of-the-art evidence, and Dr. Vipperman, see, e.g., Pet. 29-30.
`
`This combination is compelling despite the district court construing terms
`
`within the ’357 patent to be indefinite. Claim Construction Order, Jawbone
`
`Innovations, LLC v. Google LLC, No. 6:21-cv-00985-ADA, Dkt. 88 at 4 (W.D. Tex.
`
`Oct. 14, 2022) (“Claim Construction Order”; Ex. 1023). The linear responses to
`
`speech shown to be obvious in the petition look like Figures 9 and 11 of the ’357
`
`patent, which are described as having different speech responses. Compare Pet. 38-
`
`39, with Ex. 1001, Figs. 9, 11, 12:55-58. The linear responses to noise shown to be
`
`obvious in the petition look like Figures 10 and 12 of the ’357 patent, which are
`
`described as having “very similar” noise responses. Compare Pet. 37-38, with
`
`Ex. 1001, Figs. 10, 12, 11:44-49, 12:44-48. The Board does not need to know the
`
`outer bounds of “substantially similar” and “substantially dissimilar” to determine
`
`that Kanamori, McCowan, and Elko render an embodiment within the scope of these
`
`terms obvious.
`
`
`
`2
`
`
`
`II. The Fintiv Factors Favor Institution
`In addition to the merits, the Fintiv factors either favor institution or are
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 11,122,357
`
`neutral. The Board should institute review.
`
`A. Fintiv Factors 2, 3, 4, and 6 Favor Institution
`Factor 2 favors institution because, to the extent the trial proceeds on the ’357
`
`patent, the Board’s projected final written decision date (January 6, 2024), as
`
`explained below, is before the expected trial date based on the median time to trial
`
`(January 30, 2024). Int. Procedure at 8-9. Patent Owner relies on the scheduled trial
`
`date for this factor. Prelim. Resp. 17-20. But a court’s scheduled trial date is often
`
`“unreliable” and “not by itself a good indicator of whether the district court trial will
`
`occur before the statutory deadline for a final written decision.” Int. Procedure at 8.
`
`To better assess time to trial, the Board should consider the “median time-to-trial,”
`
`and “the number of cases before the judge . . . and the speed and availability of other
`
`case dispositions.” Id. at 8-9.
`
`The median time from the filing of a civil case to trial in the Western District
`
`of Texas is 28.3 months, placing the expected trial date in the parallel litigation
`
`around January 30, 2024. Ex. 1019, 5. This is after the January 6, 2024 statutory
`
`deadline for a final written decision. Judge Albright’s high volume of open patent
`
`cases—848 as of August 2022—also makes it less likely that trial will proceed on
`
`schedule. Ex. 1020, 68. The Markman hearing occurred nearly three months after its
`
`
`
`3
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 11,122,357
`originally scheduled date, further demonstrating that the scheduled trial date is not
`
`reliable. Compare Ex. 1014, 2 (July 27, 2022), with Ex. 1021 (Oct. 14, 2022).
`
`Even relying on the now-expected trial date of October 13, 2023 (52 weeks
`
`from Markman), Ex. 1021; Ex. 1022, 14, this factor is neutral. DJI Europe B.V. v.
`
`Textron Innov’s Inc., IPR2022-00162, Paper 11 at 10-11 (June 7, 2022) (neutral
`
`when the scheduled trial was two months before projected FWD). Patent Owner’s
`
`cited cases do not dictate otherwise, Prelim. Resp. 16-17, as they involved larger
`
`gaps between dates, and all but one predate Fintiv and apply a different analysis.
`
`Factor 3 favors institution because the litigation is still in its early stages and
`
`Petitioner diligently filed its Petition. The district court’s Claim Construction Order
`
`is the only substantive order related to the ’357 patent. When the Board issues its
`
`institution decision, the parties will have expended few resources. Fact discovery
`
`only opened on July 28, 2022, Ex. 1014, 2, and does not close until four months after
`
`the projected institution decision, Ex. 1021; Ex. 1022, 14. The deadline for opening
`
`expert reports will not occur until May 19, 2023. Ex. 1021; Ex. 1022, 14. This factor
`
`favors institution. Progenity, Inc. v. Natera, Inc., IPR2021-00267, Paper 11 at 62-
`
`63 (June 7, 2021). Patent Owner’s lone cited case is inapposite because, there, the
`
`institution decision issued after the completion of fact and expert discovery,
`
`dispositive motions, and motions in limine, none of which is true here. See Prelim.
`
`Resp. 18 (citing Supercell, IPR2020-00513, Paper 11 at 11-12).
`
`
`
`4
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 11,122,357
`Factor 4 favors institution. The scheduled trial likely will have no overlap with
`
`this proceeding based on the court’s Claim Construction Order. Also, if the Board
`
`institutes review, Petitioner stipulates that it will not challenge the validity of the
`
`’357 patent in the parallel litigation based on the grounds advanced in the Petition
`
`or on any ground that utilizes Kanamori (Ex. 1005). Microsoft Corp. v. WSOU Invs.,
`
`LLC, IPR2021-00930, Paper 8 at 11 (Dec. 2, 2021).
`
`Factor 6 favors institution for the reasons stated in the Petition. Pet. 76-77.
`
`Patent Owner has not identified any allegedly cumulative references.
`
`Factors 1 and 5 Are Neutral
`B.
`Factor 1 is neutral where neither party has requested a stay of the litigation at
`
`the time of institution. Pet. 77; Sand Revolution II, LLC v. Continental Intermodal
`
`Grp.–Trucking LLC, IPR2019-01393, Paper 24 at 7 (June 16, 2020) (informative).
`
`Factor 5 is also neutral, despite Petitioner and defendant being the same parties in
`
`the district court case. See Protect Animals With Satellites v. OnPoint Sys., LLC,
`
`IPR2021-01483, Paper 11 at 17 (Mar. 4, 2022).
`
`III. Conclusion
`For these reasons and those in the petition, the Board should decline to
`
`exercise its discretion under 35 U.S.C. § 314(a) and should institute review.
`
`Dated: October 24, 2022
`
`
`
`
`
`
`
`
`By: /Daniel C. Cooley/
` Daniel C. Cooley
` Backup Counsel for Petitioner
` Reg. No. 59,639
`
`
`
`
`
`
`
`5
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 11,122,357
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing PETITIONER’S
`
`PRE-INSTITUTION REPLY was served on October 24, 2022, via email
`
`directed to counsel of record for the Patent Owner at the following:
`
`
`Peter Lambrianakos
`plambrianakos@fabricantllp.com
`
`Vincent J. Rubino, III
`vrubino@fabricantllp.com
`
`Alfred R. Fabricant
`ffabricant@fabricantllp.com
`
`Enrique W. Iturralde
`eiturralde@fabricantllp.com
`
`Richard Cowell
`rcowell@fabricantllp.com
`
`PTAB@fabricantllp.com
`
`
`
`Dated: October 24, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`By: /Lisa C. Hines/
` Lisa C. Hines
` Senior Litigation Legal Assistant
` Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`
`
`
`
`
`6
`
`